To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
GTCR earmarks $250m for medical device platform
The Chicago-based buyout firm’s investment, being made from its $2.75bn Fund IX, will help establish Devicor Medical Products. It agreed a similar $200m deal last month in the human resource information sector.
